Skip to search formSkip to main contentSkip to account menu
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
TLDR
The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.
View on Publisher
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
TLDR
Risk of Bias In Non-randomised Studies - of Interventions is developed, a new tool for evaluating risk of bias in estimates of the comparative effectiveness of interventions from studies that did not use randomisation to allocate units or clusters of individuals to comparison groups.
View on BMJ
RoB 2: a revised tool for assessing risk of bias in randomised trials
TLDR
The Cochrane risk-of-bias tool has been updated to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
View on Publisher
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
View on Elsevier
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
TLDR
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation are published, with a focus on patients with a history of prior heart failure.
View on PubMed
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic…
TLDR
Authors/Task Force members: Stephan Windecker* (ESC Chairperson), Philippe Kolh* (EACTS Chairperson) (Belgium), Jean-Philippe Collet (France), Jochen Cremer (Germany), Volkmar Falk (Switzerland), Gerasimos Filippatos (Greece), Christian Hamm (Germany) and Stuart J. Head (The Netherlands).
View PDF
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.
TLDR
In patients with stable coronary artery disease and functionally significant stenoses, FFR-guided PCI plus the best available medical therapy, as compared with the best Available medical therapy alone, decreased the need for urgent revascularization.
View on PubMed
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
View on Elsevier
Assessing the quality of controlled clinical trials
TLDR
The concept of study quality and the methods used to assess quality are discussed and the methodology for both the assessment of quality and its incorporation into systematic reviews and meta-analysis is discussed.
View on Publisher
The hazards of scoring the quality of clinical trials for meta-analysis.
TLDR
The data indicate that the use of summary scores to identify trials of high quality is problematic, and relevant methodological aspects should be assessed individually and their influence on effect sizes explored.
View on PubMed
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License